| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Breast cancer
Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes
Xin Li, Zehao Li, Lin Li, Tong Liu, Cheng Qian, Yanlv Ren, Zhigao Li, Kejin Chen, Dongchen Ji, Ming Zhang, Jinsong Wang
Cancer Res Treat. 2024;56(1):134-142.   Published online August 14, 2023    DOI: https://doi.org/10.4143/crt.2023.652
                        
Breast Cancer
Implications of Tamoxifen Resistance in Palbociclib Efficacy for Patients with Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Subgroup Analyses of KCSG-BR15-10 (YoungPEARL)
Jiyun Lee, Seock-Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Yeon Hee Park
Cancer Res Treat. 2021;53(3):695-702.   Published online December 17, 2020    DOI: https://doi.org/10.4143/crt.2020.1246
                           Web of Science 2  Crossref 1
Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer
Guiyun Sohn, Sei Hyun Ahn, Hee Jeong Kim, Byung-Ho Son, Jong Won Lee, Beom Seok Ko, Yura Lee, Sae Byul Lee, Seunghee Baek
Cancer Res Treat. 2016;48(4):1351-1362.   Published online April 6, 2016    DOI: https://doi.org/10.4143/crt.2015.444
                           Web of Science 7  Crossref 6
Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage Breast Cancers
Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho
Cancer Res Treat. 2006;38(3):126-132.   Published online June 30, 2006    DOI: https://doi.org/10.4143/crt.2006.38.3.126
                           Crossref 12
Effects of Polyamines on TNFalpha- or Tamoxifen-induced Apoptosis in Human Breast Cancer Cells
Ji Young Kim, Ki Young Kim, Kyeong Hee Lee, Ki Whan Hong, Byeong Gee Kim
Cancer Res Treat. 2001;33(5):385-391.   Published online October 31, 2001    DOI: https://doi.org/10.4143/crt.2001.33.5.385
         Crossref 1
The Effect of Long-term Tamoxifen Therapy on Endometrium Evaluated by Transvaginal Sonography in Postmenopausal Women Undergone Breast Cancer Surgery
Jung Hoon Bae, Lee Su Kim, Jeong Jin Kim, Min Kyun Lim, Jong Hyun Kim, Young Min Woo, Man Chul Park, Dong Kun Kim, Chang Sig Choi, Sung Kim
J Korean Cancer Assoc. 2000;32(3):539-544.
      
The Role of bcl-2 and p53 in Tamoxifen-Induced Apoptosis of Human Breast Cancer Cell Lines
Woo Chul Noh, Dong Young Noh, Yong Ho Ham, Chang Min Kim, Nam Sun Paik, Nan Mo Moon, Kuk Jin Choe
J Korean Cancer Assoc. 2000;32(3):531-538.
      
Restoration of Hormone Dependency in Estrogen Receptor - Lipofected MDA-MB-231 Human Breast Cancer Cells
Young Jin Suh, Jae Hee Chang, Chung Soo Chun
J Korean Cancer Assoc. 1999;31(3):473-482.
      
Transforming growth Factor - beta ( TGF-β ) as a Mediator of Tamoxifen and Retinoic Acid in Breast Carcer
Hy Do Lee, Dong Sup Yoon, Chul Woon Jung, Ja Yun Koo
J Korean Cancer Assoc. 1996;28(3):443-451.
      
Reversal of ( MDR ) Multidrug resistance ) in Adiamycin - Resistant MCF - 7 Cells by Tamoxifen : Possible Role of Protedin Kinase ( PCK )
Han Lim Moon, Hoon Kyo Kim, Kyung Shik Lee
J Korean Cancer Assoc. 1994;26(2):242-249.
      
Endoxifen Concentration is Associated with Recurrence-Free Survival in Hormone-Sensitive Breast Cancer Patients
Beomki Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jeong Eon Lee, Soo-Youn Lee
Received December 5, 2023   Accepted June 16, 2024   Published online June 18, 2024
DOI: https://doi.org/10.4143/crt.2023.1285    
[Accepted]
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.1
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI